methyltestosterone has been researched along with fulvestrant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brown, KM; Goering, PL; Papaconstantinou, AD; Umbreit, TH | 1 |
1 review(s) available for methyltestosterone and fulvestrant
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for methyltestosterone and fulvestrant
| Article | Year |
|---|---|
Effects of 17 alpha-methyltestosterone on uterine morphology and heat shock protein expression are mediated through estrogen and androgen receptors.
Topics: Androgen Antagonists; Animals; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Estradiol; Estrogen Antagonists; Female; Flutamide; Fulvestrant; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Immunoenzyme Techniques; Membrane Proteins; Methyltestosterone; Mice; Organ Size; Ovariectomy; Receptors, Androgen; Receptors, Estrogen; Testosterone Congeners; Uterus | 2002 |